Key result
Anxiety symptoms are linked to ~69% lower odds of metabolic syndrome, while depression shows no association.
Why the study?
Are anxiety and depression symptoms associated with the prevalence of metabolic syndrome and its individual components in community-dwelling Iranian adults?
Cross-Sectional (n=470)
Are anxiety and depression symptoms associated with the prevalence of metabolic syndrome and its individual components in community-dwelling Iranian adults?
Answers are grounded in this paper and cite their sources.
In this Iranian community cohort, self-reported anxiety symptoms were associated with lower odds of metabolic syndrome, whereas depressive symptoms showed no independent association after multivariable adjustment.
BACKGROUND: Only a few studies have carried out to evaluate the association of depression and anxiety with metabolic syndrome (MetS). The aim of this study was to investigate whether the depression and anxiety are associated with MetS and its different components. MATERIALS AND METHODS: This cross-sectional study forms part of the prospective Isfahan Cohort Study. A total of 470 participants were chosen. Anxiety and depression symptoms were measured using hospital anxiety and depression scale (HADS). The MetS was diagnosed according to the American Heart Association and National Heart, Lung, and Blood Institute. One-way analysis of variance and binary logistic regression were used. Moreover, the analysis showed that having anxiety symptoms is in a negative relationship with MetS (odds ratio [OR] = 0.31; 95% confidence interval [CI] = 0.12-0.78). In addition, with each 10-year increase in age, the probability of MetS will decrease 40% (OR = 0.59; 95%Cl = 0.53-0.72). Body mass index (OR = 1.29; 95%CI = 1.21-1.37), and gender (higher age for women) (OR = 0.34; 95%CI = 0.11-0.98) had positive relationship with MetS. CONCLUSION: The study findings revealed that the prevalence of MetS in patients with anxiety was lower than the healthy subjects, while no significant association was found between depression, concurrent depression, an anxiety with MetS.
No takes yet. Share an insight, caveat, or question.
Akbari et al. (2017) conducted a cross-sectional in Metabolic syndrome, anxiety, and depression (n=470). Anxiety and depression symptoms (measured by Hospital Anxiety and Depression Scale [HADS] >=8) vs. Reference control group without anxiety or depression symptoms (both HADS-A and HADS-D <8) was evaluated on Metabolic syndrome (diagnosed according to AHA/NHLBI update of NCEP-ATP III criteria) (OR 0.31, 95% CI 0.12-0.78). Anxiety symptoms were negatively associated with metabolic syndrome, whereas depression showed no significant association.
Synapse has enriched 10 related papers. Consider them for comparative context: